BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/21/2020 5:47:11 AM | Browse: 43 | Download: 33
Publication Name World Journal of Clinical Cases
Manuscript ID 59240
Country/Territory China
Category Infectious Diseases
Manuscript Type Retrospective Cohort Study
Article Title Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
Manuscript Source Unsolicited Manuscript
All Author List Ci Tian, Nan Li, Yi Bai, Han Xiao, Shu Li, Qing-Gang Ge, Ning Shen and Qing-Bian Ma
Funding Agency and Grant Number
Corresponding author Qing-Bian Ma, MD, Associate Professor, Chairman, Chief Physician, Department of Emergency Medicine, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing 100191, China. maqingbian@bjmu.edu.cn
Key Words COVID-19; Hypertension; Angiotensin converting enzymes inhibitors; Angiotensin receptor blockers; Angiotensin-converting enzyme-2; Prognosis
Core Tip Recent research revealed that the ingestion of angiotensin converting enzymes inhibitors or angiotensin receptor blockers (ACEIs/ARBs) had no significant harm on coronavirus disease 2019 (COVID-19) patients complicated with hypertension. However, the impact of discontinue using ACEIs/ARBs in those patients was still unclearly. In the present study, we retrospectively collected the clinical data of patients with both COVID-19 and hypertension, and to explore whether any difference in disease outcomes occurred between patients who discontinued using ACEIs/ARBs and those who continued using other anti-hypertensive drugs.
Citation Tian C, Li N, Bai Y, Xiao H, Li S, Ge QG, Shen N, Ma QB. Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension. World J Clin Cases 2020; In press
2020-10-09 09:17
Peer-Review Started
2020-10-09 09:17
To Make the First Decision
Return for Revision
2020-11-03 00:39
2020-11-09 07:59
Second Decision
2020-11-16 11:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-11-21 05:47
Articles in Press
2020-11-21 05:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Assistant Editor Assistant Editor
Science Editor Chen-Chen Gao
Reviewer Code 01705318, and 01524425
Editorial Director
Journal Chief Editor
Company Chief Editor Lian-Sheng Ma
Language Editor
Production Editor
Responsible Production Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma
Manuscript File 59240_Auto_Edited.docx
Answering Reviewers 59240-Answering reviewers.pdf
Audio Core Tip 59240-Audio core tip.m4a
Biostatistics Review Certificate 59240-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 59240-Conflict-of-interest statement.pdf
Copyright License Agreement 59240-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 59240-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 59240-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 59240-Language certificate.pdf
Supplementary Material 59240-Supplementary material.pdf
Peer-review Report 59240-Peer-review(s).pdf
Scientific Misconduct Check 59240-Scientific misconduct check.pdf
Scientific Editor Work List 59240-Scientific editor work list.pdf